Bandingkan Harga & Kinerja Mutuagung Lestari Tbk. (MUTU) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mutuagung Lestari Tbk. dan Organon Pharma Indonesia Tbk.: Mutuagung Lestari Tbk. diperdagangkan di Rp135 (kapitalisasi pasar 403,91 M, volume 24 jam 528,16 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mutuagung Lestari Tbk. jauh lebih besar — sekitar 3,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MUTU | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 403,91 M | 104,4 M |
Volume | 528,16 jt | — |
Lot | 5,28 jt | — |
Perputaran | 73,81 M | — |
Harga Rata-rata | 139,74 | — |
Nilai Transaksi | 73,81 M | — |
Harga Ekuilibrium Indikatif | 135 | — |
Volume Ekuilibrium Indikatif | 180,89 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mutuagung Lestari Tbk.
PT Mutuagung Lestari Tbk (the Company) was established in the Republic of Indonesia based on Deed No. 6 dated March 2, 1990 of Jacinta Susanti, S.H., Notary in Jakarta. The Company started its commercial operations in 1990.
Selengkapnya di halaman MUTU →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
